IKS Health Announces Strategic Acquihire of AI Company ThinkDTM to Expand Patient Access Solutions

Inventurus Knowledge Solutions Limited has announced a strategic acquihire that significantly expands its AI capabilities in healthcare operations. Through its subsidiary IKS Health, the company has acquired ThinkDTM, an AI-native product, strategy, and digital services company, marking a key step in strengthening its patient access solutions portfolio.

Strategic Leadership Addition

The acquihire brings ThinkDTM Founder Tij Bedi into IKS Health as Executive Vice President and General Manager, Patient Access and Innovation. Bedi's established team of AI technology experts will integrate into IKS Health's operations, bringing specialized expertise in artificial intelligence implementation.

Role Details:	Information
New Position:	Executive Vice President and General Manager, Patient Access and Innovation
Background:	Engineer and problem solver with AI expertise
Team Integration:	Complete ThinkDTM AI technology expert team
Focus Area:	Patient access solutions and innovation

"As healthcare continues to be disrupted, joining IKS Health is a tremendous opportunity to intelligently implement AI in ways that make patients' lives easier," Bedi commented on the acquisition.

Expansion of Patient Access Solutions

The newly expanded team will focus on transforming IKS Health's patient access solutions portfolio across multiple areas:

Patient scheduling systems
Registration processes
Demographic capture capabilities
Insurance eligibility verification
Prior authorization workflows

The integration aims to build and scale differentiated patient access solutions while strengthening platform capabilities and driving innovation that enhances outcomes for both healthcare providers and patients.

Strategic AI Implementation

Sachin K. Gupta, Founder and Global CEO of IKS Health, emphasized the strategic importance of the acquisition in the company's AI development. "Tij and his team are critical additions to our growing team of AI engineers and experts, particularly as we lean into the world of agentic AI and its role in our continued growth and scale in revenue optimization and beyond," Gupta stated.

The acquisition positions IKS Health to leverage agentic AI workflows combined with human expertise to create more accurate operations and better outcomes across the healthcare journey.

Company Background and Recognition

IKS Health operates as a global leader in care enablement solutions, focusing on reducing administrative, clinical, and operational burdens in healthcare. The company has received multiple industry recognitions:

Recognition:	Details
Black Book:	Top provider of AI-driven RCM services
KLAS:	Performance and client satisfaction
Google Cloud:	DORA Award for "Augmenting Human Expertise with AI"
Founded:	2006
Market Presence:	Partnerships with largest US health systems and physician groups

Inventurus Knowledge Solutions Limited trades on both the National Stock Exchange of India Limited and BSE Limited, positioning the company in the public markets as it expands its healthcare technology capabilities through strategic acquisitions like ThinkDTM.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.23%	+4.44%	-3.22%	-8.39%	-10.46%	-32.10%

Inventurus Knowledge Solutions Limited has completed a significant investment in its wholly owned subsidiary, acquiring shares worth over USD 19 million as part of its expansion strategy. The company informed stock exchanges about this development through a regulatory filing dated March 27, 2026.

Investment Details

The company has successfully acquired shares in Inventurus Knowledge Solutions, Inc. (IKS Inc.), its wholly owned subsidiary, as the first tranche of a previously approved investment plan.

Parameter:	Details
Shares Acquired:	29,541 shares
Investment Amount:	USD 19,000,476
Investment Type:	First tranche
Subsidiary:	Inventurus Knowledge Solutions, Inc.

Regulatory Compliance

The investment follows proper regulatory procedures under SEBI LODR Regulations. The company had initially disclosed the Board's approval for this investment on March 13, 2026, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The latest disclosure was made under Regulation 30(7) of the SEBI LODR Regulations, providing an update on the actual execution of the previously approved investment plan. Both BSE and NSE were informed about this development through formal communication.

Strategic Significance

This substantial investment in IKS Inc. represents Inventurus Knowledge Solutions' commitment to strengthening its subsidiary operations. The acquisition of nearly 30,000 shares demonstrates the company's confidence in its US-based subsidiary's growth potential and strategic importance to the overall business structure.

The investment was executed by Company Secretary and Compliance Officer Sameer Chavan, ensuring proper documentation and regulatory compliance throughout the process.